Cargando…

Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials

SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparri, Maria Luisa, Kuehn, Thorsten, Ruscito, Ilary, Zuber, Veronica, Di Micco, Rosa, Galiano, Ilaria, Navarro Quinones, Siobana C., Santurro, Letizia, Di Vittorio, Francesca, Meani, Francesco, Bassi, Valerio, Ditsch, Nina, Mueller, Michael D., Bellati, Filippo, Caserta, Donatella, Papadia, Andrea, Gentilini, Oreste D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123055/
https://www.ncbi.nlm.nih.gov/pubmed/33923153
http://dx.doi.org/10.3390/cancers13092056
_version_ 1783692792817516544
author Gasparri, Maria Luisa
Kuehn, Thorsten
Ruscito, Ilary
Zuber, Veronica
Di Micco, Rosa
Galiano, Ilaria
Navarro Quinones, Siobana C.
Santurro, Letizia
Di Vittorio, Francesca
Meani, Francesco
Bassi, Valerio
Ditsch, Nina
Mueller, Michael D.
Bellati, Filippo
Caserta, Donatella
Papadia, Andrea
Gentilini, Oreste D.
author_facet Gasparri, Maria Luisa
Kuehn, Thorsten
Ruscito, Ilary
Zuber, Veronica
Di Micco, Rosa
Galiano, Ilaria
Navarro Quinones, Siobana C.
Santurro, Letizia
Di Vittorio, Francesca
Meani, Francesco
Bassi, Valerio
Ditsch, Nina
Mueller, Michael D.
Bellati, Filippo
Caserta, Donatella
Papadia, Andrea
Gentilini, Oreste D.
author_sort Gasparri, Maria Luisa
collection PubMed
description SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is an experimental procedure to reduce lymphatic morbidity. The aim of our systematic review and meta-analysis is to investigate the effects of fibrin sealants on lymphatic morbidity after axillary dissection. Our results show that this experimental procedure is able to decrease the total axillary drainage output, the number of days before the axillary drainage is removed, and the length of hospital stay. However, no effects on the occurrence rate of axillary lymphocele or on the surgical site complications rate were demonstrated ABSTRACT: Background: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. Methods: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. Results: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin’s disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). Conclusion: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found.
format Online
Article
Text
id pubmed-8123055
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81230552021-05-16 Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials Gasparri, Maria Luisa Kuehn, Thorsten Ruscito, Ilary Zuber, Veronica Di Micco, Rosa Galiano, Ilaria Navarro Quinones, Siobana C. Santurro, Letizia Di Vittorio, Francesca Meani, Francesco Bassi, Valerio Ditsch, Nina Mueller, Michael D. Bellati, Filippo Caserta, Donatella Papadia, Andrea Gentilini, Oreste D. Cancers (Basel) Systematic Review SIMPLE SUMMARY: Axillary dissection is a highly mobile procedure with severe lymphatic consequences. The off-label application of fibrin sealants in the axilla, with the sole aim to eliminate dead space and to provoke sealing of the disrupted lymphatic vessels at the end of axillary dissection, is an experimental procedure to reduce lymphatic morbidity. The aim of our systematic review and meta-analysis is to investigate the effects of fibrin sealants on lymphatic morbidity after axillary dissection. Our results show that this experimental procedure is able to decrease the total axillary drainage output, the number of days before the axillary drainage is removed, and the length of hospital stay. However, no effects on the occurrence rate of axillary lymphocele or on the surgical site complications rate were demonstrated ABSTRACT: Background: use of fibrin sealants following pelvic, paraaortic, and inguinal lymphadenectomy may reduce lymphatic morbidity. The aim of this meta-analysis is to evaluate if this finding applies to the axillary lymphadenectomy. Methods: randomized trials evaluating the efficacy of fibrin sealants in reducing axillary lymphatic complications were included. Lymphocele, drainage output, surgical-site complications, and hospital stay were considered as outcomes. Results: twenty-three randomized studies, including patients undergoing axillary lymphadenectomy for breast cancer, melanoma, and Hodgkin’s disease, were included. Fibrin sealants did not affect axillary lymphocele incidence nor the surgical site complications. Drainage output, days with drainage, and hospital stay were reduced when fibrin sealants were applied (p < 0.0001, p < 0.005, p = 0.008). Conclusion: fibrin sealants after axillary dissection reduce the total axillary drainage output, the duration of drainage, and the hospital stay. No effects on the incidence of postoperative lymphocele and surgical site complications rate are found. MDPI 2021-04-24 /pmc/articles/PMC8123055/ /pubmed/33923153 http://dx.doi.org/10.3390/cancers13092056 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Gasparri, Maria Luisa
Kuehn, Thorsten
Ruscito, Ilary
Zuber, Veronica
Di Micco, Rosa
Galiano, Ilaria
Navarro Quinones, Siobana C.
Santurro, Letizia
Di Vittorio, Francesca
Meani, Francesco
Bassi, Valerio
Ditsch, Nina
Mueller, Michael D.
Bellati, Filippo
Caserta, Donatella
Papadia, Andrea
Gentilini, Oreste D.
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title_full Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title_fullStr Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title_full_unstemmed Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title_short Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
title_sort fibrin sealants and axillary lymphatic morbidity: a systematic review and meta-analysis of 23 clinical randomized trials
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123055/
https://www.ncbi.nlm.nih.gov/pubmed/33923153
http://dx.doi.org/10.3390/cancers13092056
work_keys_str_mv AT gasparrimarialuisa fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT kuehnthorsten fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT ruscitoilary fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT zuberveronica fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT dimiccorosa fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT galianoilaria fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT navarroquinonessiobanac fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT santurroletizia fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT divittoriofrancesca fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT meanifrancesco fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT bassivalerio fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT ditschnina fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT muellermichaeld fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT bellatifilippo fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT casertadonatella fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT papadiaandrea fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials
AT gentiliniorested fibrinsealantsandaxillarylymphaticmorbidityasystematicreviewandmetaanalysisof23clinicalrandomizedtrials